Clinical Trials Directory

Trials / Completed

CompletedNCT01537302

Chronic Total Occlusion Crossing With the Ocelot System - CONNECT II

A Non-randomized Study of the Avinger Ocelot System Used to Cross Chronic Total Occlusions in the Superficial Femoral and Popliteal Arteries

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Avinger, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Evaluation of the safety and effectiveness of the Ocelot System to provide OCT-assisted orientation while simultaneously crossing totally occluded femoropopliteal arteries.

Detailed description

The purpose of this clinical study is to evaluate the safety and effectiveness of the Ocelot System to provide OCT-assisted orientation while simultaneously crossing chronic total occlusions (CTOs) in femoropopliteal arteries. The Ocelot Catheter is a minimally invasive percutaneous device that is designed to traverse arterial occlusions through the use of spiral wedges contained in the distal tip of the device. The device is also equipped with an OCT (optical coherence tomography) imaging fiber that provides directional orientation and an intravascular view of the vessel wall and target lesion. The Ocelot Catheter is used in conjunction with standard endovascular devices and as an adjunct to fluoroscopic guidance.

Conditions

Interventions

TypeNameDescription
DEVICECTO crossing in femoropopliteal arteries CONNECT IICTO crossing in femoropopliteal arteries using the Ocelot System

Timeline

Start date
2012-02-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2012-02-23
Last updated
2021-03-22
Results posted
2015-03-18

Locations

17 sites across 3 countries: United States, Germany, Italy

Source: ClinicalTrials.gov record NCT01537302. Inclusion in this directory is not an endorsement.